Share Price and Basic Stock Data
Last Updated: December 13, 2025, 7:55 am
| PEG Ratio | -8.40 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
GHCL Ltd, a notable player in the chemicals sector, specifically in inorganic chemicals like caustic soda and soda ash, has seen significant fluctuations in its revenue over the past few quarters. For the fiscal year ending March 2023, the company reported a remarkable sales figure of ₹4,551 Cr, a substantial increase compared to ₹3,052 Cr in FY 2022. However, the subsequent quarters have shown a downward trend, with sales declining to ₹3,149 Cr for the trailing twelve months (TTM). The most recent quarter, September 2023, recorded sales at ₹805 Cr, reflecting a sharp drop from the previous year’s ₹1,381 Cr in the same quarter. This volatility raises questions about the sustainability of GHCL’s revenue, especially given the competitive landscape and global market dynamics. Overall, while the company has experienced growth, the recent downturn suggests challenges that could impact future performance.
Profitability and Efficiency Metrics
GHCL’s profitability metrics present a mixed picture. The operating profit margin (OPM) stood at a commendable 25% for the fiscal year ending March 2025, indicative of the company’s ability to manage its costs effectively. However, OPM has shown a downward trend, declining from 33% in FY 2023 to 28% in FY 2025. This trend is concerning as it suggests increasing costs or potential pricing pressures in the market. The net profit for the same period was reported at ₹624 Cr, a decrease from ₹1,142 Cr in FY 2023, reflecting the challenges in maintaining profitability amidst declining sales. Furthermore, the return on equity (ROE) was reported at 17.88%, which, while respectable, has decreased from 28.85% in FY 2023. These metrics indicate that while GHCL has historically managed to generate solid profits, the recent trends could signal operational inefficiencies or increased market competition that investors should monitor closely.
Balance Sheet Strength and Financial Ratios
GHCL’s balance sheet appears robust, with total assets reported at ₹4,185 Cr and minimal borrowings of ₹97 Cr, highlighting a low debt-to-equity ratio of 0.02. This low leverage could provide the company with financial flexibility for future investments or to weather economic downturns. The interest coverage ratio (ICR), an impressive 59.78x, indicates that GHCL comfortably meets its interest obligations, which is a strong point for any investor. Additionally, the company has accumulated reserves of ₹3,540 Cr, reflecting a significant cushion for potential downturns. However, the cash conversion cycle (CCC) has increased to 183 days, suggesting that GHCL may take longer to convert its investments in inventory and receivables back into cash. This could pose liquidity risks if not managed effectively, especially in a fluctuating market.
Shareholding Pattern and Investor Confidence
The shareholding structure of GHCL Ltd shows a healthy mix of institutional and public investors, which can provide stability and confidence in the stock. As of March 2025, foreign institutional investors (FIIs) held 26.41% of the shares, demonstrating significant interest from outside investors. Domestic institutional investors (DIIs) accounted for 10.28%, while public shareholders constituted 44.32%. This broad base of shareholders suggests a level of confidence in the company’s strategy and performance. However, the promoters’ stake has seen a slight decline to 18.97%, which may raise concerns about management’s commitment to the company. The total number of shareholders has also decreased to 96,988, indicating potential volatility in investor sentiment. A declining number of shareholders could reflect a lack of confidence or interest in the stock, which investors should consider when evaluating GHCL’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, GHCL faces a mix of opportunities and challenges. The company’s strong balance sheet and low debt levels provide a solid foundation for future growth, but recent revenue declines and profitability pressures are concerning. The chemical industry is highly competitive and sensitive to global economic shifts, which could impact GHCL’s sales and margins. Additionally, the rising cash conversion cycle might indicate operational inefficiencies that need addressing. Investors should remain vigilant about potential market fluctuations and the company’s ability to adapt to changing conditions. Overall, while GHCL has demonstrated historical strength, the current trends suggest a need for careful monitoring and strategic adjustments to navigate the evolving landscape effectively. As always, potential investors should weigh these factors against their risk tolerance and investment horizon before making decisions regarding GHCL Ltd’s stock.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 27.5 Cr. | 59.8 | 69.0/37.5 | 2,749 | 11.6 | 0.00 % | 0.48 % | 13.7 % | 10.0 |
| Standard Industries Ltd | 103 Cr. | 16.0 | 30.6/15.4 | 20.4 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 3,725 Cr. | 507 | 788/484 | 24,833 | 759 | 3.12 % | 0.34 % | 1.13 % | 10.0 |
| GHCL Ltd | 5,297 Cr. | 576 | 779/511 | 9.30 | 378 | 2.08 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 19,332 Cr. | 759 | 1,107/747 | 59.3 | 877 | 1.45 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 5,824.20 Cr | 396.63 | 5,539.02 | 389.00 | 1.15% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,148 | 1,381 | 1,102 | 1,120 | 1,019 | 805 | 798 | 823 | 830 | 793 | 779 | 781 | 796 |
| Expenses | 789 | 947 | 735 | 771 | 719 | 592 | 648 | 639 | 614 | 582 | 549 | 563 | 599 |
| Operating Profit | 359 | 434 | 367 | 349 | 299 | 213 | 150 | 184 | 217 | 211 | 230 | 218 | 197 |
| OPM % | 31% | 31% | 33% | 31% | 29% | 26% | 19% | 22% | 26% | 27% | 30% | 28% | 25% |
| Other Income | 128 | 1 | 4 | -3 | 230 | 11 | 14 | 17 | 18 | 17 | 29 | 23 | 27 |
| Interest | 10 | 11 | 10 | 10 | 8 | 7 | 6 | 5 | 4 | 4 | 4 | 4 | 2 |
| Depreciation | 22 | 32 | 22 | 27 | 24 | 26 | 26 | 26 | 27 | 28 | 28 | 28 | 27 |
| Profit before tax | 455 | 392 | 339 | 309 | 497 | 191 | 133 | 170 | 203 | 196 | 227 | 209 | 195 |
| Tax % | 19% | 25% | 26% | 27% | 14% | 25% | 25% | 26% | 26% | 21% | 26% | 28% | 26% |
| Net Profit | 369 | 293 | 252 | 227 | 426 | 143 | 100 | 125 | 151 | 155 | 168 | 150 | 144 |
| EPS in Rs | 38.56 | 30.60 | 26.38 | 23.70 | 44.60 | 14.94 | 10.43 | 13.04 | 15.73 | 16.17 | 17.59 | 15.69 | 15.00 |
Last Updated: August 1, 2025, 9:05 pm
Below is a detailed analysis of the quarterly data for GHCL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 796.00 Cr.. The value appears strong and on an upward trend. It has increased from 781.00 Cr. (Mar 2025) to 796.00 Cr., marking an increase of 15.00 Cr..
- For Expenses, as of Jun 2025, the value is 599.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 563.00 Cr. (Mar 2025) to 599.00 Cr., marking an increase of 36.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 197.00 Cr.. The value appears to be declining and may need further review. It has decreased from 218.00 Cr. (Mar 2025) to 197.00 Cr., marking a decrease of 21.00 Cr..
- For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 28.00% (Mar 2025) to 25.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 195.00 Cr.. The value appears to be declining and may need further review. It has decreased from 209.00 Cr. (Mar 2025) to 195.00 Cr., marking a decrease of 14.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 26.00%, marking a decrease of 2.00%.
- For Net Profit, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 15.00. The value appears to be declining and may need further review. It has decreased from 15.69 (Mar 2025) to 15.00, marking a decrease of 0.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:19 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,201 | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,551 | 3,447 | 3,183 | 3,149 |
| Expenses | 1,767 | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,596 | 2,306 | 2,292 |
| Operating Profit | 434 | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,503 | 851 | 877 | 856 |
| OPM % | 20% | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 25% | 28% | 27% |
| Other Income | -26 | -15 | -3 | 37 | 38 | 16 | 16 | 18 | 211 | 119 | 270 | 88 | 96 |
| Interest | 183 | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 27 | 17 | 14 |
| Depreciation | 82 | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 102 | 112 | 111 |
| Profit before tax | 143 | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 991 | 836 | 827 |
| Tax % | 24% | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | 20% | 25% | |
| Net Profit | 109 | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 794 | 624 | 618 |
| EPS in Rs | 10.85 | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119.41 | 82.94 | 65.18 | 64.45 |
| Dividend Payout % | 18% | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% | 14% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 66.97% | 41.76% | 47.29% | -6.32% | -1.40% | 13.11% | -17.88% | 99.39% | 75.69% | -30.47% | -21.41% |
| Change in YoY Net Profit Growth (%) | 0.00% | -25.21% | 5.53% | -53.60% | 4.91% | 14.51% | -30.99% | 117.27% | -23.69% | -106.17% | 9.06% |
GHCL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 30% |
| 3 Years: | -1% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 22% |
| 3 Years: | 23% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 4:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 | 96 |
| Reserves | 487 | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,393 | 3,540 |
| Borrowings | 1,486 | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 119 | 97 |
| Other Liabilities | 941 | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 578 | 540 |
| Total Liabilities | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
| Fixed Assets | 1,869 | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,844 | 1,842 |
| CWIP | 12 | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 256 | 370 |
| Investments | 7 | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 651 | 831 |
| Other Assets | 1,125 | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,435 | 1,229 |
| Total Assets | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
Below is a detailed analysis of the balance sheet data for GHCL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 96.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 96.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,540.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,393.00 Cr. (Mar 2025) to 3,540.00 Cr., marking an increase of 147.00 Cr..
- For Borrowings, as of Sep 2025, the value is 97.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 119.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 22.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 540.00 Cr.. The value appears to be improving (decreasing). It has decreased from 578.00 Cr. (Mar 2025) to 540.00 Cr., marking a decrease of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,272.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,842.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,844.00 Cr. (Mar 2025) to 1,842.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 370.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 370.00 Cr., marking an increase of 114.00 Cr..
- For Investments, as of Sep 2025, the value is 831.00 Cr.. The value appears strong and on an upward trend. It has increased from 651.00 Cr. (Mar 2025) to 831.00 Cr., marking an increase of 180.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,229.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,435.00 Cr. (Mar 2025) to 1,229.00 Cr., marking a decrease of 206.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
Notably, the Reserves (3,540.00 Cr.) exceed the Borrowings (97.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 433.00 | 527.00 | 628.00 | 680.00 | 606.00 | 758.00 | 728.00 | -177.00 | -58.00 | -360.00 | 641.00 | 758.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 | 24 |
| Inventory Days | 227 | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 | 217 |
| Days Payable | 233 | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 55 | 57 |
| Cash Conversion Cycle | 57 | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 149 | 183 |
| Working Capital Days | -52 | -39 | -48 | -30 | -12 | 10 | 26 | 61 | 87 | 50 | 50 | 58 |
| ROCE % | 17% | 22% | 25% | 24% | 19% | 21% | 19% | 16% | 19% | 36% | 21% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 2,600,000 | 0.99 | 166.45 | 3,115,010 | 2025-12-07 00:37:57 | -16.53% |
| Franklin India Small Cap Fund | 1,449,472 | 0.67 | 92.8 | N/A | N/A | N/A |
| DSP ELSS Tax Saver Fund | 1,447,019 | 0.54 | 92.64 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 850,000 | 0.63 | 54.42 | N/A | N/A | N/A |
| UTI Large & Mid Cap Fund | 603,132 | 0.73 | 38.61 | 228,863 | 2025-12-07 08:32:39 | 163.53% |
| UTI Aggressive Hybrid Fund | 572,260 | 0.56 | 36.64 | 541,859 | 2025-12-08 03:26:51 | 5.61% |
| HDFC Dividend Yield Fund | 400,000 | 0.4 | 25.61 | N/A | N/A | N/A |
| UTI Retirement Fund | 191,742 | 0.26 | 12.28 | 206,707 | 2025-12-07 08:32:39 | -7.24% |
| Mahindra Manulife Flexi Cap Fund | 170,000 | 0.69 | 10.88 | N/A | N/A | N/A |
| Mahindra Manulife ELSS Tax Saver Fund | 85,000 | 0.56 | 5.44 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 65.50 | 83.43 | 120.06 | 67.89 | 34.32 |
| Diluted EPS (Rs.) | 65.34 | 83.33 | 120.06 | 67.89 | 34.23 |
| Cash EPS (Rs.) | 76.83 | 93.61 | 129.28 | 80.36 | 48.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Revenue From Operations / Share (Rs.) | 332.48 | 360.06 | 475.51 | 397.68 | 305.24 |
| PBDIT / Share (Rs.) | 100.65 | 94.00 | 159.03 | 104.32 | 69.80 |
| PBIT / Share (Rs.) | 89.00 | 83.33 | 149.17 | 92.03 | 55.76 |
| PBT / Share (Rs.) | 87.32 | 103.58 | 153.05 | 85.34 | 46.16 |
| Net Profit / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| NP After MI And SOA / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| PBDIT Margin (%) | 30.27 | 26.10 | 33.44 | 26.23 | 22.86 |
| PBIT Margin (%) | 26.76 | 23.14 | 31.37 | 23.14 | 18.26 |
| PBT Margin (%) | 26.26 | 28.76 | 32.18 | 21.45 | 15.12 |
| Net Profit Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| NP After MI And SOA Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| Return on Networth / Equity (%) | 17.88 | 26.65 | 28.85 | 20.96 | 13.12 |
| Return on Capital Employeed (%) | 22.32 | 23.76 | 31.97 | 22.97 | 15.93 |
| Return On Assets (%) | 14.91 | 21.06 | 22.23 | 12.94 | 8.19 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.06 | 0.13 | 0.22 |
| Total Debt / Equity (X) | 0.02 | 0.06 | 0.08 | 0.24 | 0.24 |
| Asset Turnover Ratio (%) | 0.80 | 0.77 | 0.89 | 0.84 | 0.69 |
| Current Ratio (X) | 5.31 | 4.30 | 4.69 | 1.82 | 1.71 |
| Quick Ratio (X) | 3.61 | 2.73 | 3.54 | 1.03 | 0.53 |
| Inventory Turnover Ratio (X) | 1.46 | 1.55 | 1.49 | 1.75 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 18.32 | 20.96 | 12.49 | 8.08 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.54 | 18.57 | 11.54 | 6.84 | 0.00 |
| Earning Retention Ratio (%) | 81.68 | 79.04 | 87.51 | 91.92 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.46 | 81.43 | 88.46 | 93.16 | 0.00 |
| Interest Coverage Ratio (X) | 59.78 | 35.33 | 39.31 | 15.59 | 7.27 |
| Interest Coverage Ratio (Post Tax) (X) | 39.72 | 23.56 | 27.90 | 10.41 | 4.58 |
| Enterprise Value (Cr.) | 5531.62 | 3948.48 | 5021.66 | 5717.82 | 2744.15 |
| EV / Net Operating Revenue (X) | 1.74 | 1.15 | 1.10 | 1.51 | 0.94 |
| EV / EBITDA (X) | 5.74 | 4.39 | 3.30 | 5.77 | 4.14 |
| MarketCap / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| Retention Ratios (%) | 81.67 | 79.03 | 87.50 | 91.91 | 0.00 |
| Price / BV (X) | 1.69 | 1.42 | 1.22 | 1.69 | 0.88 |
| Price / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| EarningsYield | 0.10 | 0.18 | 0.23 | 0.12 | 0.14 |
After reviewing the key financial ratios for GHCL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 65.50. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 65.50, marking a decrease of 17.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 65.34. This value is within the healthy range. It has decreased from 83.33 (Mar 24) to 65.34, marking a decrease of 17.99.
- For Cash EPS (Rs.), as of Mar 25, the value is 76.83. This value is within the healthy range. It has decreased from 93.61 (Mar 24) to 76.83, marking a decrease of 16.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 332.48. It has decreased from 360.06 (Mar 24) to 332.48, marking a decrease of 27.58.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 100.65. This value is within the healthy range. It has increased from 94.00 (Mar 24) to 100.65, marking an increase of 6.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 89.00. This value is within the healthy range. It has increased from 83.33 (Mar 24) to 89.00, marking an increase of 5.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 87.32. This value is within the healthy range. It has decreased from 103.58 (Mar 24) to 87.32, marking a decrease of 16.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For PBDIT Margin (%), as of Mar 25, the value is 30.27. This value is within the healthy range. It has increased from 26.10 (Mar 24) to 30.27, marking an increase of 4.17.
- For PBIT Margin (%), as of Mar 25, the value is 26.76. This value exceeds the healthy maximum of 20. It has increased from 23.14 (Mar 24) to 26.76, marking an increase of 3.62.
- For PBT Margin (%), as of Mar 25, the value is 26.26. This value is within the healthy range. It has decreased from 28.76 (Mar 24) to 26.26, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 19.60. This value exceeds the healthy maximum of 10. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.60. This value is within the healthy range. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 26.65 (Mar 24) to 17.88, marking a decrease of 8.77.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.32. This value is within the healthy range. It has decreased from 23.76 (Mar 24) to 22.32, marking a decrease of 1.44.
- For Return On Assets (%), as of Mar 25, the value is 14.91. This value is within the healthy range. It has decreased from 21.06 (Mar 24) to 14.91, marking a decrease of 6.15.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has increased from 0.77 (Mar 24) to 0.80, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 5.31. This value exceeds the healthy maximum of 3. It has increased from 4.30 (Mar 24) to 5.31, marking an increase of 1.01.
- For Quick Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 2. It has increased from 2.73 (Mar 24) to 3.61, marking an increase of 0.88.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 4. It has decreased from 1.55 (Mar 24) to 1.46, marking a decrease of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.32. This value is below the healthy minimum of 20. It has decreased from 20.96 (Mar 24) to 18.32, marking a decrease of 2.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.54. This value is below the healthy minimum of 20. It has decreased from 18.57 (Mar 24) to 15.54, marking a decrease of 3.03.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.68. This value exceeds the healthy maximum of 70. It has increased from 79.04 (Mar 24) to 81.68, marking an increase of 2.64.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.46. This value exceeds the healthy maximum of 70. It has increased from 81.43 (Mar 24) to 84.46, marking an increase of 3.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 59.78. This value is within the healthy range. It has increased from 35.33 (Mar 24) to 59.78, marking an increase of 24.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 39.72. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 39.72, marking an increase of 16.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,531.62. It has increased from 3,948.48 (Mar 24) to 5,531.62, marking an increase of 1,583.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.74, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 25, the value is 5.74. This value is within the healthy range. It has increased from 4.39 (Mar 24) to 5.74, marking an increase of 1.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For Retention Ratios (%), as of Mar 25, the value is 81.67. This value exceeds the healthy maximum of 70. It has increased from 79.03 (Mar 24) to 81.67, marking an increase of 2.64.
- For Price / BV (X), as of Mar 25, the value is 1.69. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.69, marking an increase of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GHCL Ltd:
- Net Profit Margin: 19.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.32% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 39.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.3 (Industry average Stock P/E: 5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | GHCL House, Opp. Punjabi Hall, Ahmedabad Gujarat 380009 | ghclinfo@ghcl.co.in http://www.ghcl.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Dalmia | Non Executive Chairman |
| Mr. R S Jalan | Managing Director |
| Mr. Raman Chopra | Executive Director (Finance) & CFO |
| Mr. Neelabh Dalmia | Executive Director |
| Mrs. Vijaylaxmi Joshi | Independent Director |
| Dr. Manoj Vaish | Independent Director |
| Justice(Retd) Ravindra Singh | Independent Director |
| Mr. Arun Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of GHCL Ltd?
GHCL Ltd's intrinsic value (as of 13 December 2025) is 533.97 which is 7.30% lower the current market price of 576.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,297 Cr. market cap, FY2025-2026 high/low of 779/511, reserves of ₹3,540 Cr, and liabilities of 4,272 Cr.
What is the Market Cap of GHCL Ltd?
The Market Cap of GHCL Ltd is 5,297 Cr..
What is the current Stock Price of GHCL Ltd as on 13 December 2025?
The current stock price of GHCL Ltd as on 13 December 2025 is 576.
What is the High / Low of GHCL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of GHCL Ltd stocks is 779/511.
What is the Stock P/E of GHCL Ltd?
The Stock P/E of GHCL Ltd is 9.30.
What is the Book Value of GHCL Ltd?
The Book Value of GHCL Ltd is 378.
What is the Dividend Yield of GHCL Ltd?
The Dividend Yield of GHCL Ltd is 2.08 %.
What is the ROCE of GHCL Ltd?
The ROCE of GHCL Ltd is 24.2 %.
What is the ROE of GHCL Ltd?
The ROE of GHCL Ltd is 18.6 %.
What is the Face Value of GHCL Ltd?
The Face Value of GHCL Ltd is 10.0.